Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2026 15:30 ET | Source: Custom Market Insights

[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Deep Eutectic Solvents Market Size, Trends and Insights By Product (Organic...
August 05, 2026 12:30 ET | Source: Custom Market Insights

[Latest] Global Generative AI In Clinical Trials Market Size/Share Worth USD 1.86 Billion by 2035 at a 9.63% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Generative Ai In Clinical Trials Market Size, Trends and Insights By Deployment...
August 05, 2026 00:30 ET | Source: Custom Market Insights

[Latest] Global eClinical Solutions Market Size/Share Worth USD 42.55 Billion by 2035 at a 13.98% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “eClinical Solutions Market Size, Trends and Insights By Product (Electronic Data...
August 04, 2026 09:07 ET | Source: Alembic Therapeutics

Alembic Therapeutics LLC Announces Availability of Ciprofloxacin Otic Solution 0.2%

BEDMINSTER, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC announces the U.S. availability of Ciprofloxacin Otic Solution 0.2%, an FDA-approved, AB-rated, quinolone antimicrobial...
August 04, 2026 07:00 ET | Source: Vantage Biosciences

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy

Vantage Biosciences completes enrollment in the Phase 2 SeeClear study of oral oruvestat in non-proliferative diabetic retinopathy.
July 29, 2026 08:32 ET | Source: SciSparc Ltd

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company

TEL AVIV, Israel, July 29, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage...
July 28, 2026 00:30 ET | Source: Custom Market Insights

Global Pharmaceutical Surfactants Market Size/Share Worth USD 6.93 Billion by 2035 at a 4.42% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

AUSTIN, TX, USA, July 28, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Pharmaceutical Surfactants Market Size, Trends and Insights By Type (Non-ionic...
July 27, 2026 08:25 ET | Source: SciSparc Ltd

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

TEL AVIV, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its board of directors has made a decision to target the agentic...
July 24, 2026 10:04 ET | Source: BCC Research LLC

AI-Powered Wound Care Market Poised for Revolutionary Disruption as Investment Activity Surges

AI is transforming biologic wound care through earlier diagnosis, better healing predictions, improved therapy selection, and faster clinical research.
July 23, 2026 00:10 ET | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL implements strategic reorganisation to refocus on U.S. markets

MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and...